Chile's medicines regulator and national reference laboratory. It registers medicines within six months by the ordinary route, and since 2020 within three months for a medicine already registered for the same use by a stringent regulator; biological medicines are excluded from that fast route unless the Minister exempts them.
The Instituto de Salud Pública states that its origins go back to the Instituto de Higiene of 1892 and the Instituto Bacteriológico de Chile of 1939, which became the ISP in 1979, and that since 2016 the Pan American Health Organization has certified it as a level 4 regional reference regulatory authority for medicines. Under the Código Sanitario no medicine may be distributed in Chile without registration, and the ISP keeps the register.
Decreto 3 de 2010, the regulation of the national system for controlling medicines, sets a total of six months from payment of the fee for the ordinary registration route (article 47), and five months for its simplified route (article 52). Decreto 54 de 2019, published on 21 August 2020, added an accelerated route (articles 54 A to 54 G) for medicines registered for the same indication by a high-surveillance regulator, defined as a WHO-listed stringent regulatory authority, a PAHO level IV authority or a PIC/S member: the applicant files the dossier given to that regulator, the ISP takes its review into account, and the procedure may not exceed three months unless the applicant must correct the file. It is closed to medicines refused by any such agency and, unless the Minister of Health exempts them by resolution, to biological medicines. Article 21 lets the ISP authorise use of an unregistered medicine in urgent shortage, for personal import or for a clinical trial. OnCo did not find published measured approval times for cancer medicines. The coordinates are a Santiago city point.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-11-19.
Matched to Instituto de Salud Pública de Chile, including child institutions. 4 works · 0 citations · 75% open access · 0% clinical trials · 0% reviews.
| Work | Journal | Year | Citations |
|---|---|---|---|
| Territorial inequalities in cancer mortality in Chile, 2002–2022: a rurality-continuum analysis using spatiotemporal Bayesian models 10.1016/j.ypmed.2026.108575 | Preventive Medicine | 2026 | 0 |
| Differences in Hospital Discharges Between Younger and Older Women With Breast Cancer in Chile, 2004–2024: A Nationwide Retrospective Observational Study | SSRN Electronic Journal | 2026 | 0 |
| Breast cancer diagnosis and staging in Chile: A non-randomized survey-based study to assess frequency and delays 10.5867/medwave.2024.09.2801 · open access | Medwave | 2024 | 0 |
| EE483 The Economic Impact of Coronavirus Pandemic on Stroke Care: Direct and Indirect Costs Estimations in Chile | Value in Health | 2022 | 0 |
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/